Acinic cell carcinoma differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 6: Line 6:
==Overview==
==Overview==


 
Acinic cell carcinoma is a head and neck tumor happening in the salivary glands. If a patient was observed with related signs, the tumor must be classified as a benign or invasive by the capsule being intact. Differential diagnosis of a malignant tumor in salivary gland is made after the incision and by histology features which will provide a good chemotherapy regimen for so called patients.
==Differentiating acinic cell carcinoma from other Diseases==
==Differentiating acinic cell carcinoma from other Diseases==


===Differentiating acinic cell carcinoma from other diseases on the basis of histology findings===
===Differentiating acinic cell carcinoma from other diseases on the basis of histology findings===


On the basis of histologic findings acinic cell carcinoma must be differentiated from other salivary and head and neck masses such as salivary metastasis of thyroid carcinoma, salivary oncocytoma, mucoepidermoid carcinoma, inconspicuous mucous/squamoid cells, Mammary analog secretory carcinoma.<ref>{{cite journal|title=Tumors of the Salivary Glands, Atlas of Tumor Pathology: Third Series, Fascicle 17 G. L. Ellis and P. L. Auclair. Armed Forces Institute of Pathology, Washington D.C. ISBN: 1 881041 26 3 (Printed). 1996. Price: $69.00. ISBN: 1 881041 41 7 (CD-ROM). 1998. Price: $65.00|journal=The Journal of Pathology|volume=192|issue=4|year=2000|pages=564–565|issn=0022-3417|doi=10.1002/1096-9896(200012)192:4<564::AID-PATH737>3.0.CO;2-M}}</ref><ref name="Kumar2017">{{cite journal|last1=Kumar|first1=Uma|title=Acinic Cell Carcinoma Papillary-Cystic Variant: Diagnostic Pitfalls in Fine Needle Aspiration Cytology|journal=JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH|year=2017|issn=2249782X|doi=10.7860/JCDR/2017/21347.9772}}</ref>
On the basis of histologist findings acinic cell carcinoma must be differentiated from other salivary and head and neck masses such as salivary metastasis of thyroid carcinoma, salivary oncocytoma, mucoepidermoid carcinoma, inconspicuous mucous/squamoid cells, Mammary analog secretory carcinoma.<ref>{{cite journal|title=Tumors of the Salivary Glands, Atlas of Tumor Pathology: Third Series, Fascicle 17 G. L. Ellis and P. L. Auclair. Armed Forces Institute of Pathology, Washington D.C. ISBN: 1 881041 26 3 (Printed). 1996. Price: $69.00. ISBN: 1 881041 41 7 (CD-ROM). 1998. Price: $65.00|journal=The Journal of Pathology|volume=192|issue=4|year=2000|pages=564–565|issn=0022-3417|doi=10.1002/1096-9896(200012)192:4<564::AID-PATH737>3.0.CO;2-M}}</ref><ref name="Kumar2017">{{cite journal|last1=Kumar|first1=Uma|title=Acinic Cell Carcinoma Papillary-Cystic Variant: Diagnostic Pitfalls in Fine Needle Aspiration Cytology|journal=JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH|year=2017|issn=2249782X|doi=10.7860/JCDR/2017/21347.9772}}</ref>


{| class="wikitable"
{| class="wikitable"
Line 22: Line 22:
| style="background: #4479BA; color: #FFFFFF; text-align: center;" |Distinguishing features
| style="background: #4479BA; color: #FFFFFF; text-align: center;" |Distinguishing features
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Salivary metastasis of thyroid carcinoma
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Salivary gland tumor|Salivary]] [[metastasis]] of [[thyroid carcinoma]]<ref name="SamsGnepp2012">{{cite journal|last1=Sams|first1=Ralph N.|last2=Gnepp|first2=Douglas R.|title=P63 Expression Can Be Used in Differential Diagnosis of Salivary Gland Acinic Cell and Mucoepidermoid Carcinomas|journal=Head and Neck Pathology|volume=7|issue=1|year=2012|pages=64–68|issn=1936-055X|doi=10.1007/s12105-012-0403-2}}</ref>
| style="background: #F5F5F5; padding: 5px;" |Empty appearance, grooves, pseudoinclusions
| style="background: #F5F5F5; padding: 5px;" |Empty appearance, grooves, pseudoinclusions
| style="background: #F5F5F5; padding: 5px;" |Immunohistochemistry (Tyrogloubin)
| style="background: #F5F5F5; padding: 5px;" |Immunohistochemistry (Tyrogloubin)
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |salivary oncocytoma
| style="background: #DCDCDC; padding: 5px; text-align: center;" |salivary oncocytoma<ref name="SchwartzBegum2013">{{cite journal|last1=Schwartz|first1=Lauren E.|last2=Begum|first2=Shahnaz|last3=Westra|first3=William H.|last4=Bishop|first4=Justin A.|title=GATA3 Immunohistochemical Expression in Salivary Gland Neoplasms|journal=Head and Neck Pathology|volume=7|issue=4|year=2013|pages=311–315|issn=1936-055X|doi=10.1007/s12105-013-0442-3}}</ref>
| style="background: #F5F5F5; padding: 5px;" |Eosinophilic, non-serous cells
| style="background: #F5F5F5; padding: 5px;" |Eosinophilic, non-serous cells
| style="background: #F5F5F5; padding: 5px;" |Hematoxylin
| style="background: #F5F5F5; padding: 5px;" |Hematoxylin
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |mucoepidermoid carcinoma
| style="background: #DCDCDC; padding: 5px; text-align: center;" |mucoepidermoid carcinoma<ref name="PatelSolomon20132">{{cite journal|last1=Patel|first1=Kalyani R.|last2=Solomon|first2=Isaac H.|last3=El-Mofty|first3=Samir K.|last4=Lewis|first4=James S.|last5=Chernock|first5=Rebecca D.|title=Mammaglobin and S-100 immunoreactivity in salivary gland carcinomas other than mammary analogue secretory carcinoma|journal=Human Pathology|volume=44|issue=11|year=2013|pages=2501–2508|issn=00468177|doi=10.1016/j.humpath.2013.06.010}}</ref>
| style="background: #F5F5F5; padding: 5px;" |Microcystic, and follicula, inconspicuous mucous/squamoid cells, eosinophilic
| style="background: #F5F5F5; padding: 5px;" |Microcystic, and follicula, inconspicuous mucous/squamoid cells, eosinophilic
| style="background: #F5F5F5; padding: 5px;" |Immunohistochemistry for p63
| style="background: #F5F5F5; padding: 5px;" |Immunohistochemistry for p63
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Mammary analoge secretory carcinoma
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Mammary analoge secretory carcinoma<ref name="pmid10421256">{{cite journal| author=Castle JT, Thompson LD, Frommelt RA, Wenig BM, Kessler HP| title=Polymorphous low grade adenocarcinoma: a clinicopathologic study of 164 cases. | journal=Cancer | year= 1999 | volume= 86 | issue= 2 | pages= 207-19 | pmid=10421256 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10421256  }}</ref>
| style="background: #F5F5F5; padding: 5px;" |Histologically similar
| style="background: #F5F5F5; padding: 5px;" |Histologically similar
| style="background: #F5F5F5; padding: 5px;" |Lack of PAS-positive secretory granules, Vimentin positive, Adipophilin positive  
| style="background: #F5F5F5; padding: 5px;" |Lack of PAS-positive secretory granules, Vimentin positive, Adipophilin positive  

Revision as of 13:58, 12 September 2019

Acinic cell carcinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Acinic cell carcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Surgery

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case studies

Case #1

Acinic cell carcinoma differential diagnosis On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Acinic cell carcinoma differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Acinic cell carcinoma differential diagnosis

CDC on Acinic cell carcinoma differential diagnosis

Acinic cell carcinoma differential diagnosis in the news

Blogs on Acinic cell carcinoma differential diagnosis

Directions to Hospitals Treating Acinic cell carcinoma

Risk calculators and risk factors for Acinic cell carcinoma differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ramyar Ghandriz MD[2]

Overview

Acinic cell carcinoma is a head and neck tumor happening in the salivary glands. If a patient was observed with related signs, the tumor must be classified as a benign or invasive by the capsule being intact. Differential diagnosis of a malignant tumor in salivary gland is made after the incision and by histology features which will provide a good chemotherapy regimen for so called patients.

Differentiating acinic cell carcinoma from other Diseases

Differentiating acinic cell carcinoma from other diseases on the basis of histology findings

On the basis of histologist findings acinic cell carcinoma must be differentiated from other salivary and head and neck masses such as salivary metastasis of thyroid carcinoma, salivary oncocytoma, mucoepidermoid carcinoma, inconspicuous mucous/squamoid cells, Mammary analog secretory carcinoma.[1][2]

Histological findings
Diseases Overlapping features Distinguishing features
Salivary metastasis of thyroid carcinoma[3] Empty appearance, grooves, pseudoinclusions Immunohistochemistry (Tyrogloubin)
salivary oncocytoma[4] Eosinophilic, non-serous cells Hematoxylin
mucoepidermoid carcinoma[5] Microcystic, and follicula, inconspicuous mucous/squamoid cells, eosinophilic Immunohistochemistry for p63
Mammary analoge secretory carcinoma[6] Histologically similar Lack of PAS-positive secretory granules, Vimentin positive, Adipophilin positive

References

  1. "Tumors of the Salivary Glands, Atlas of Tumor Pathology: Third Series, Fascicle 17 G. L. Ellis and P. L. Auclair. Armed Forces Institute of Pathology, Washington D.C. ISBN: 1 881041 26 3 (Printed). 1996. Price: $69.00. ISBN: 1 881041 41 7 (CD-ROM). 1998. Price: $65.00". The Journal of Pathology. 192 (4): 564–565. 2000. doi:10.1002/1096-9896(200012)192:4<564::AID-PATH737>3.0.CO;2-M. ISSN 0022-3417.
  2. Kumar, Uma (2017). "Acinic Cell Carcinoma Papillary-Cystic Variant: Diagnostic Pitfalls in Fine Needle Aspiration Cytology". JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH. doi:10.7860/JCDR/2017/21347.9772. ISSN 2249-782X.
  3. Sams, Ralph N.; Gnepp, Douglas R. (2012). "P63 Expression Can Be Used in Differential Diagnosis of Salivary Gland Acinic Cell and Mucoepidermoid Carcinomas". Head and Neck Pathology. 7 (1): 64–68. doi:10.1007/s12105-012-0403-2. ISSN 1936-055X.
  4. Schwartz, Lauren E.; Begum, Shahnaz; Westra, William H.; Bishop, Justin A. (2013). "GATA3 Immunohistochemical Expression in Salivary Gland Neoplasms". Head and Neck Pathology. 7 (4): 311–315. doi:10.1007/s12105-013-0442-3. ISSN 1936-055X.
  5. Patel, Kalyani R.; Solomon, Isaac H.; El-Mofty, Samir K.; Lewis, James S.; Chernock, Rebecca D. (2013). "Mammaglobin and S-100 immunoreactivity in salivary gland carcinomas other than mammary analogue secretory carcinoma". Human Pathology. 44 (11): 2501–2508. doi:10.1016/j.humpath.2013.06.010. ISSN 0046-8177.
  6. Castle JT, Thompson LD, Frommelt RA, Wenig BM, Kessler HP (1999). "Polymorphous low grade adenocarcinoma: a clinicopathologic study of 164 cases". Cancer. 86 (2): 207–19. PMID 10421256.

Template:WH Template:WS